Louise Kirman
Novartis (United States)(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Enzyme Catalysis and Immobilization, Pharmaceutical and Antibiotic Environmental Impacts, Pancreatic function and diabetes, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 Diabetes(2009)91 cited
- → Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway(2012)47 cited
- → Avoidance of the Ames test liability for aryl–amines via computation(2011)32 cited
- → Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach(2020)22 cited
- → Transaminases Provide Key Chiral Building Blocks for the Synthesis of Selective M1/M4 Agonists(2023)2 cited